Janux Therapeutics Overview
Janux Therapeutics Target Price
Analysts' 12-month price predictions for JANX.
Get informed when a big investor buys or sells
+ FollowShare Price
$14.64
Average Target Price
$21.75
48.6% upside
48.6% upside4 analysts in the last 4 months
High: $36 | Low: $14
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-11 | Evercore ISI | $22 | 50.3% upside |  |
| 2026-05-08 | Wedbush | $36 | 145.9% upside | |
| 2026-04-20 | BarclaysEtzer Darout | $14 |  4.4% downside | |
| 2026-04-15 | UBS | $15 | 2.5% upside | |
| 2026-01-16 | Piper SandlerKelsey Goodwin | $30 | 104.9% upside | |
| 2025-12-17 | Barclays | $29 | 98.1% upside | |
| 2025-12-02 | UBSDavid Dai | $57 | 289.3% upside | |
| 2025-12-02 | Stifel NicolausStephen Willey | $38 | 159.6% upside | |
| 2025-12-02 | H.C. Wainwright | $45 | 207.4% upside | |
| 2025-09-16 | Barclays | $47 | 221% upside | |
| 2025-09-10 | Stifel Nicolaus | $45 | 207.4% upside | |
| 2025-09-03 | GuggenheimBrad Canino | $72 | 391.8% upside | |
| 2025-07-11 | Raymond JamesSean McCutcheon | $65 | 344% upside | |
| 2025-02-28 | Scotiabank | $41 | 180.1% upside | |
| 2025-02-28 | Wedbush | $76 | 419.1% upside | |
| 2024-12-03 | BTIGJustin Zelin | $100 | 583.1% upside | |
| 2024-10-24 | UBSDavid Dai | $69 | 371.3% upside | |
| 2024-09-05 | Stifel NicolausBradley Canino | $70 | 378.1% upside | |
| 2024-08-09 | ScotiabankGeorge Farmer | $42 | 186.9% upside | |
| 2024-05-30 | ScotiabankGeorge Farmer | $47 | 221% upside | |
| 2024-05-13 | H.C. WainwrightSwayampakula Ramakanth | $63 | 330.3% upside | |
| 2024-03-20 | BTIGKaveri Pohlman | $62 | 323.5% upside | |